추천 제품
vapor pressure
190 mmHg ( 25 °C)
품질
Dilute to 6L to conform to USP & EP
유통기한
limited shelf life, expiry date on the label
농도
0.00990-0.01010 N (after dilution)
bp
100 °C (lit.)
SMILES string
Cl
InChI
1S/ClH/h1H
InChI key
VEXZGXHMUGYJMC-UHFFFAOYSA-N
유사한 제품을 찾으십니까? 방문 제품 비교 안내
애플리케이션
Dissolution Media Concentrates have been formulated to allow quick and easy dilution to a working solution. The label on each bottle indicates the volume of concentrate in the bottle and the volume to which it must be diluted to provide a final media solution that meets the applicable pharmacopoeia specifications. The user friendly format is designed so that each bottle is a single use unit. The instructions below illustrate just how easy it is to prepare the media.
1. Prepare a clean, dry mixing vessel of a suitable size, 6L, 10L or 25L.
2. Add purified water to approximately one third of the required volume i.e. 2L, 3L or 8L.
3. Carefully pour the entire contents of the bottle of concentrate into the vessel.
4. Rinse the bottle with purified water and add rinsing′s to the mixing vessel.
5. Add purified water to the required volume.
6. Mix thoroughly.
7. Measure the pH and proceed if within specification.
8. Adjust pH if necessary.
1. Prepare a clean, dry mixing vessel of a suitable size, 6L, 10L or 25L.
2. Add purified water to approximately one third of the required volume i.e. 2L, 3L or 8L.
3. Carefully pour the entire contents of the bottle of concentrate into the vessel.
4. Rinse the bottle with purified water and add rinsing′s to the mixing vessel.
5. Add purified water to the required volume.
6. Mix thoroughly.
7. Measure the pH and proceed if within specification.
8. Adjust pH if necessary.
신호어
Warning
유해 및 위험 성명서
예방조치 성명서
Hazard Classifications
Met. Corr. 1
Storage Class Code
8B - Non-combustible corrosive hazardous materials
WGK
nwg
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
가장 최신 버전 중 하나를 선택하세요:
Sandra Donkervoort et al.
Human mutation, 36(1), 48-56 (2014-09-11)
Collagen 6-related dystrophies and myopathies (COL6-RD) are a group of disorders that form a wide phenotypic spectrum, ranging from severe Ullrich congenital muscular dystrophy, intermediate phenotypes, to the milder Bethlem myopathy. Both inter- and intrafamilial variable expressivity are commonly observed.
Jay G Hosking et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(4), 1005-1015 (2014-10-21)
Successful decision making often requires weighing a given option's costs against its associated benefits, an ability that appears perturbed in virtually every severe mental illness. Animal models of such cost/benefit decision making overwhelmingly implicate mesolimbic dopamine in our willingness to
Robert Goldstein et al.
European journal of nuclear medicine and molecular imaging, 42(2), 288-301 (2014-11-14)
Human epidermal growth factor receptor-2 (HER2) overexpression is a predictor of response to anti-HER2 therapy in breast and gastric cancer. Currently, HER2 status is assessed by tumour biopsy, but this may not be representative of the larger tumour mass or
Mahsa Sadeghi et al.
British journal of pharmacology, 172(2), 460-468 (2014-01-01)
Tapentadol is a novel analgesic that combines moderate μ-opioid receptor agonism and noradrenaline reuptake inhibition in a single molecule. Both mechanisms of action are involved in producing analgesia; however, the potency and efficacy of tapentadol in individual neurons has not
Ann Brinkmalm et al.
Molecular neurodegeneration, 9, 53-53 (2014-11-25)
Synaptic degeneration is an early pathogenic event in Alzheimer's disease, associated with cognitive impairment and disease progression. Cerebrospinal fluid biomarkers reflecting synaptic integrity would be highly valuable tools to monitor synaptic degeneration directly in patients. We previously showed that synaptic
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.